These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24515615)

  • 1. Reinterpretation of the vibrational spectroscopy of the medicinal bioinorganic synthon c,c,t-[Pt(NH3)2Cl2(OH)2].
    Johnstone TC; Lippard SJ
    J Biol Inorg Chem; 2014 Jun; 19(4-5):667-74. PubMed ID: 24515615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.
    Tolbatov I; Coletti C; Marrone A; Re N
    Inorg Chem; 2018 Mar; 57(6):3411-3419. PubMed ID: 29509010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric environmental effects on the structure and vibrations of cis-[Pt(NH3)2Cl2] in condensed phases.
    Zhang C; Naziga EB; Guidoni L
    J Phys Chem B; 2014 Oct; 118(39):11487-95. PubMed ID: 25144652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.
    Almotairy ARZ; Montagner D; Morrison L; Devereux M; Howe O; Erxleben A
    J Inorg Biochem; 2020 Sep; 210():111125. PubMed ID: 32521289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-platinum interactions in vitro with trans- and cis-Pt(NH3)2Cl2.
    Macquet JP; Theophanides T
    Bioinorg Chem; 1975; 5(1):59-66. PubMed ID: 1182209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
    Jin S; Hao Y; Zhu Z; Muhammad N; Zhang Z; Wang K; Guo Y; Guo Z; Wang X
    Inorg Chem; 2018 Sep; 57(17):11135-11145. PubMed ID: 30117731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
    Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
    J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel platinum-based anticancer drug: a complete vibrational study.
    Batista de Carvalho ALM; Parker SF; Batista de Carvalho LAE; Marques MPM
    Acta Crystallogr C Struct Chem; 2018 May; 74(Pt 5):628-634. PubMed ID: 29726474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
    Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
    Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar binding of the carcinostatic drugs cis-[Pt(NH3)2Cl2] and [Ru(NH3)5Cl] Cl2 to tRNAphe and a comparison with the binding of the inactive trans-[Pt(NH3)2Cl2] complex - reluctance in binding to Watson-Crick base pairs within double helix.
    Rubin JR; Sabat M; Sundaralingam M
    Nucleic Acids Res; 1983 Sep; 11(18):6571-86. PubMed ID: 6353373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position.
    Tolan D; Gandin V; Morrison L; El-Nahas A; Marzano C; Montagner D; Erxleben A
    Sci Rep; 2016 Jul; 6():29367. PubMed ID: 27404565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
    Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
    Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Condensation Reactions Involving Pt(II) /Pd(II) -OH2 , Pt-NH3 , and Cytosine-NH2 Groups: New Twists in Cisplatin-Nucleobase Chemistry.
    Yin-Bandur L; Sanz Miguel PJ; Rodríguez-Santiago L; Sodupe M; Berghaus M; Lippert B
    Chemistry; 2016 Sep; 22(38):13653-68. PubMed ID: 27516223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA.
    Blatter EE; Vollano JF; Krishnan BS; Dabrowiak JC
    Biochemistry; 1984 Oct; 23(21):4817-20. PubMed ID: 6541947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circular dichroism study of DNA.platinum complexes. Differentiation between monofunctional, cis-bidentate and trans-bidentate platinum fixation on a series of DNAs.
    Macquet JP; Butour JL
    Eur J Biochem; 1978 Feb; 83(2):375-85. PubMed ID: 631125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambidentate coordination in hydrogen bonded dimethyl sulfoxide, (CH3)2SO...H3O+, and in dichlorobis(dimethyl sulfoxide) palladium(II) and platinum(II) solid solvates, by vibrational and sulfur K-edge X-ray absorption spectroscopy.
    Risberg ED; Mink J; Abbasi A; Skripkin MY; Hajba L; Lindqvist-Reis P; Bencze E; Sandström M
    Dalton Trans; 2009 Feb; (8):1328-38. PubMed ID: 19462654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action.
    Raveendran R; Braude JP; Wexselblatt E; Novohradsky V; Stuchlikova O; Brabec V; Gandin V; Gibson D
    Chem Sci; 2016 Mar; 7(3):2381-2391. PubMed ID: 29997781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.